[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Original Article
March 1, 2008

Treatment Decision Making in Pancreatic Adenocarcinoma: Multidisciplinary Team Discussion With Multidetector-Row Computed Tomography

Author Affiliations

Author Affiliations: Divisions of Diagnostic Radiology (Dr Furukawa), Hepato-Biliary-Pancreatic Surgery (Dr Uesaka), and Gastroenterology and Endoscopy (Dr Boku), Shizuoka Cancer Center Hospital, Shizuoka, Japan.

Arch Surg. 2008;143(3):275-280. doi:10.1001/archsurg.2007.78

Hypothesis  Multidetector-row computed tomography reduces the frequency of use of other imaging methods in patients with pancreatic carcinoma.

Design  Validation cohort study.

Setting  Tertiary care public hospital.

Patients  Two hundred thirteen patients with pancreatic carcinoma.

Main Outcome Measure  Multidetector-row computed tomography was initially performed in patients with newly diagnosed pancreatic carcinoma.

Results  Of the 213 pancreatic carcinomas, 79 (37%) were classified as probably resectable, 127 (60%) as certainly unresectable, and 7 (3%) as probably unresectable. Of 79 tumors classified as probably resectable, 68 (86%) were found to be resectable, 7 tumors considered as probably unresectable were unresectable, and the remaining 127 tumors were treated nonsurgically. Magnetic resonance imaging was recommended in 92 patients (43%), angiography in 1 patient (0.5%), and both endoscopic ultrasonography and endoscopic retrograde cholangiopancreatography in 15 patients (7%).

Conclusions  Multidetector-row computed tomography provides reliable information for staging pancreatic carcinoma. Multidisciplinary team discussion along with use of this noninvasive technique simplifies the diagnostic strategy for pancreatic carcinoma and decreases the need for invasive staging methods.